Sven Ante Lundberg - May 23, 2024 Form 4 Insider Report for Vor Biopharma Inc. (VOR)

Role
Director
Signature
/s/ Katie Kazem, Attorney-in-Fact
Stock symbol
VOR
Transactions as of
May 23, 2024
Transactions value $
$0
Form type
4
Date filed
5/28/2024, 04:10 PM
Previous filing
May 9, 2024
Next filing
Sep 27, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VOR Stock Option (Right to Buy) Award $0 +30K $0.00 30K May 23, 2024 Common Stock 30K $1.61 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on the earlier of (i) May 23, 2025 or (ii) the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date.